AWA
CVS icon

Arkadios Wealth Advisors’s CVS Health CVS Stock Holding History

Arkadios Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Buy
43,998
+3,495
+9% +$312K 0.07% 289
2026
Q1 		$2.91M Sell
40,503
-480
-1% -$37K 0.05% 397
2025
Q4 		$3.25M Sell
40,983
-547
-1% -$43.1K 0.06% 314
2025
Q3 		$3.13M Sell
41,530
-728
-2% -$49.9K 0.08% 281
2025
Q2 		$2.91M Buy
42,258
+1,351
+3% +$88.6K 0.09% 254
2025
Q1 		$2.77M Buy
40,907
+10,300
+34% +$616K 0.1% 224
2024
Q4 		$1.37M Sell
30,607
-10,158
-25% -$570K 0.07% 267
2024
Q3 		$2.56M Sell
40,765
-11,165
-22% -$651K 0.15% 147
2024
Q2 		$3.07M Buy
51,930
+6,510
+14% +$407K 0.21% 100
2024
Q1 		$3.62M Buy
45,420
+3,945
+10% +$301K 0.28% 84
2023
Q4 		$3.27M Sell
41,475
-3,981
-9% -$283K 0.28% 87
2023
Q3 		$3.17M Buy
45,456
+3,164
+7% +$224K 0.3% 81
2023
Q2 		$2.92M Sell
42,292
-3,106
-7% -$221K 0.34% 70
2023
Q1 		$3.37M Buy
45,398
+3,248
+8% +$272K 0.4% 65
2022
Q4 		$3.93M Buy
42,150
+1,526
+4% +$147K 0.52% 47
2022
Q3 		$3.87M Buy
40,624
+5,300
+15% +$525K 0.59% 37
2022
Q2 		$3.27M Buy
35,324
+3,032
+9% +$296K 0.49% 48
2022
Q1 		$3.27M Buy
32,292
+2,745
+9% +$288K 0.43% 55
2021
Q4 		$3.05M Buy
29,547
+248
+0.8% +$22.9K 0.4% 62
2021
Q3 		$2.49M Sell
29,299
-801
-3% -$67.1K 0.36% 70
2021
Q2 		$2.51M Buy
30,100
+14,229
+90% +$1.17M 0.31% 85
2021
Q1 		$1.19M Buy
15,871
+3,199
+25% +$233K 0.2% 129
2020
Q4 		$865K Buy
12,672
+8,671
+217% +$564K 0.18% 125
2020
Q3 		$238K Buy
4,001
+757
+23% +$47.1K 0.12% 157
2020
Q2 		$207K Buy
3,244
+242
+8% +$15.2K 0.11% 153
2020
Q1 		$178K Buy
3,002
+1,119
+59% +$74.7K 0.11% 157
2019
Q4 		$136K Buy
+1,883
New +$132K 0.08% 195

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arkadios Wealth Advisors's CVS Position: Q2 2026 in Review

Arkadios Wealth Advisors increased its CVS Health (CVS) stake by 8.6% in Q2 2026, buying an estimated $312K and bringing the position to 43,998 shares worth $4.55M. The position accounts for 0.07% of the portfolio, ranked #289.

Arkadios Wealth Advisors first reported a position in CVS in Q4 2019 and has held it in 27 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Arkadios Wealth Advisors held 43,998 shares of CVS Health worth $4.55M as of Q2 2026.
  • Arkadios Wealth Advisors bought 3,495 CVS Health shares in Q2 2026, an estimated $312K.
  • CVS Health made up 0.07% of Arkadios Wealth Advisors's portfolio in Q2 2026, its #289 holding.
  • Arkadios Wealth Advisors first reported a position in CVS Health in Q4 2019 and has held it in 27 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Arkadios Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.